Antibodies (Part II) for Laboratory Applications
Status
Active
Submission Deadline
34 days remaining
Contracting authority
Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos (PV)21 more open tenders view
Location
Kaunas, Lithuania
Procedure
Open Procedure · Supplies
Category
Laboratory reagents.
Published
Reference
ted-596071-2026
Source
Supply of laboratory reagents (antibodies): further specifications as per the tender documents.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 596071-2026HTML
- TED PDF — 596071-2026PDF
- TED XML — 596071-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Lots (35)
- LOT-0001Antikörper C4d
- LOT-0002Antikörper CD3
- LOT-0003Antikörper CD68
- LOT-0004Antikörper: Uroplakin III
- LOT-0005Antikörper CAM 5.2 Keratin, niedriges Molekulargewicht
- LOT-0006Antikörper Amyloid A
- LOT-0007Antikörper MiFT
- LOT-0008Antikörper CD5
- LOT-0009Antikörper CD10
- LOT-0010Antikörper CD23
- LOT-0011Antikörper C1q
- LOT-0012Antikörper CD14
- LOT-0013Antikörper Mesothelin
- LOT-0014Antikörper HLA-DR
- LOT-0015Antikörper M-Laminin -alpha2 (Merosin Laminin alpha 2 Kette)
- LOT-0016Antikörper Laminin -alpha5 (Laminin alpha 5 Kette)
- LOT-0017Antikörper Laminin -beta1 (Laminin beta 1 Kette)
- LOT-0018Antikörper Laminin -beta1 (Laminin beta 1 Kette)
- LOT-0019Antikörper Skelettmuskel-alpha-Aktin
- LOT-0020Antikörper: BAP-1
- LOT-0021Antikörper anti SARS CoV-2 Spike-Glykoprotein
- LOT-0022Antikörper TOXO
- LOT-0023Antikörper TAU
- LOT-0024Antikörper: AIP (Aryl-Kohlenwasserstoff-Rezeptor-interagierendes Protein)
- LOT-0025Antikörper H3K27me3
- LOT-0026Antikörper Teletonin
- LOT-0027Antikörper HLA-DP+DQ+DR
- LOT-0028Antikörper anti-alpha-Aktinin (Sarkomer)
- LOT-0029Antikörper LDB3
- LOT-0030Antikörper Polyomavirus
- LOT-0031Antikörper LH-beta
- LOT-0032Antikörper CK6
- LOT-0033Antikörper SDHB
- LOT-0034Antikörper Glypican 3
- LOT-0035Antikörper SSTR5
Additional details
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024